Search Results

Filter
  • 1-10 of  106,468 results for ""Valproic Acid""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Factors Influencing Plasma Concentrations of Valproic Acid in Pediatric Patients With Epilepsy and the Clinical Significance of CYP2C9 Genotypes in Personalized Valproic Acid Therapy.

  • Authors : Ma B; Department of Pharmacy, Panzhihua Central Hospital, Sichuan, Panzhihua, China.; School of Pharmacy, Dali University, Yunnan, Dali, China

Subjects: Cytochrome P-450 CYP2C9*/Cytochrome P-450 CYP2C9*/Cytochrome P-450 CYP2C9*/genetics ; Epilepsy*/Epilepsy*/Epilepsy*/drug therapy ; Epilepsy*/Epilepsy*/Epilepsy*/genetics

  • Source: Therapeutic drug monitoring [Ther Drug Monit] 2024 Aug 01; Vol. 46 (4), pp. 503-511. Date of Electronic Publication: 2024 Jan 26.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 7909660 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Therapeutic effects of nanosilibinin in valproic acid-zebrafish model of autism spectrum disorder: Focusing on Wnt signaling pathway and autism spectrum disorder-related cytokines.

  • Authors : Karimi Z; Department of Neuroscience, School of Advanced Medical Science and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran.; Zarifkar A

Subjects: Zebrafish* ; Valproic Acid*/Valproic Acid*/Valproic Acid*/pharmacology ; Wnt Signaling Pathway*/Wnt Signaling Pathway*/Wnt Signaling Pathway*/drug effects

  • Source: International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience [Int J Dev Neurosci] 2024 Aug; Vol. 84 (5), pp. Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 8401784 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Model-Based Bioequivalence Analysis to Assess and Predict the Relative Bioavailability of Valproic Acid Formulations.

  • Authors : Schiavo A; Department of Pharmaceutical Sciences, Faculty of Chemistry, Universidad de la República, P.O. Box 1157, 11800, Montevideo, Uruguay.; Graduate Program in Chemistry, Faculty of Chemistry, Universidad de la República, Montevideo, Uruguay.

Subjects: Valproic Acid*/Valproic Acid*/Valproic Acid*/pharmacokinetics ; Valproic Acid*/Valproic Acid*/Valproic Acid*/administration & dosage ; Therapeutic Equivalency*

  • Source: European journal of drug metabolism and pharmacokinetics [Eur J Drug Metab Pharmacokinet] 2024 Jul; Vol. 49 (4), pp. 507-516. Date of Electronic Publication: 2024 Jun 14.Publisher: Springer France Country of Publication: France NLM ID: 7608491 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

An alpha 5-GABA A receptor positive allosteric modulator attenuates social and cognitive deficits without changing dopamine system hyperactivity in rats exposed to valproic acid in utero.

  • Authors : Souza AJ; Department of Pharmacology, Ribeirao Preto Medical School, University of São Paulo, Ribeirao Preto, Brazil.; Freitas ÍS

Subjects: Valproic Acid*/Valproic Acid*/Valproic Acid*/pharmacology ; Prenatal Exposure Delayed Effects* ; Receptors, GABA-A*/Receptors, GABA-A*/Receptors, GABA-A*/drug effects

  • Source: Autism research : official journal of the International Society for Autism Research [Autism Res] 2024 Aug; Vol. 17 (8), pp. 1534-1544. Date of Electronic Publication: 2024 Jun 22.Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101461858 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Management of the Drug-Drug Interactions Between Valproic Acid and Dolutegravir-A Case Study.

  • Authors : Cattaneo D; Gestione Ambulatoriale Politerapie (GAP) Outpatient Clinic, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy.; Department of Infectious Diseases, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy

Subjects: Heterocyclic Compounds, 3-Ring*/Heterocyclic Compounds, 3-Ring*/Heterocyclic Compounds, 3-Ring*/pharmacokinetics ; Heterocyclic Compounds, 3-Ring*/Heterocyclic Compounds, 3-Ring*/Heterocyclic Compounds, 3-Ring*/therapeutic use ; Pyridones*/Pyridones*/Pyridones*/therapeutic use

  • Source: Therapeutic drug monitoring [Ther Drug Monit] 2024 Aug 01; Vol. 46 (4), pp. 419-421. Date of Electronic Publication: 2024 May 14.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 7909660 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Short- and Long-Term Neurobehavioral Effects of Developmental Exposure to Valproic Acid in Zebrafish.

  • Authors : Ricarte M; Institute for Environmental Assessment and Water Research (IDAEA-CSIC), 08034 Barcelona, Spain.; Department of Analytical and Applied Chemistry, School of Engineering, Institut Químic de Sarrià, Universitat Ramon Llull, 08017 Barcelona, Spain.

Subjects: Zebrafish* ; Valproic Acid*/Valproic Acid*/Valproic Acid*/toxicity ; Valproic Acid*/Valproic Acid*/Valproic Acid*/adverse effects

  • Source: International journal of molecular sciences [Int J Mol Sci] 2024 Jul 13; Vol. 25 (14). Date of Electronic Publication: 2024 Jul 13.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

Record details

×
Academic Journal

Effects of (S)-3,4-DCPG, an mGlu8 receptor agonist, on hippocampal long-term potentiation at perforant pathway-dentate gyrus synapses in prenatal valproic acid-induced rat model of autism.

  • Authors : Gholipour P; Neurophysiology Research Center, Hamadan University of Medical Sciences, Shahid Fahmideh Street, Hamadan, 65178/518, Iran.; Ebrahimi Z

Subjects: Valproic Acid*/Valproic Acid*/Valproic Acid*/pharmacology ; Valproic Acid*/Valproic Acid*/Valproic Acid*/adverse effects ; Long-Term Potentiation*/Long-Term Potentiation*/Long-Term Potentiation*/drug effects

  • Source: Scientific reports [Sci Rep] 2024 Jun 07; Vol. 14 (1), pp. 13168. Date of Electronic Publication: 2024 Jun 07.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Valproic acid use is associated with diminished risk of contracting COVID-19, and diminished disease severity: Epidemiologic and in vitro analysis reveal mechanistic insights.

  • Authors : Watson A; Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases, University of Texas Health Science Center San Antonio, San Antonio, Texas, United States of America.; Shah P

Subjects: Valproic Acid*/Valproic Acid*/Valproic Acid*/pharmacology ; Valproic Acid*/Valproic Acid*/Valproic Acid*/therapeutic use ; COVID-19*/COVID-19*/COVID-19*/epidemiology

  • Source: PloS one [PLoS One] 2024 Aug 02; Vol. 19 (8), pp. e0307154. Date of Electronic Publication: 2024 Aug 02 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

Prenatal exposure to valproic acid reduces synaptic δ-catenin levels and disrupts ultrasonic vocalization in neonates.

Subjects: Valproic Acid*/Valproic Acid*/Valproic Acid*/pharmacology ; Valproic Acid*/Valproic Acid*/Valproic Acid*/toxicity ; Prenatal Exposure Delayed Effects*/Prenatal Exposure Delayed Effects*/Prenatal Exposure Delayed Effects*/chemically induced

  • Source: Neuropharmacology [Neuropharmacology] 2024 Aug 01; Vol. 253, pp. 109963. Date of Electronic Publication: 2024 Apr 23.Publisher: Pergamon Press Country of Publication: England NLM ID: 0236217 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Upregulation of Transferrin Receptor 1 (TfR1) but Not Glucose Transporter 1 (GLUT1) or CD98hc at the Blood-Brain Barrier in Response to Valproic Acid.

  • Authors : Helgudóttir SS; Neurobiology Research and Drug Delivery (NRD), Department of Health Science and Technology, Aalborg University, 9260 Gistrup, Denmark.; Johnsen KB

Subjects: Valproic Acid*/Valproic Acid*/Valproic Acid*/pharmacology ; Receptors, Transferrin*/Receptors, Transferrin*/Receptors, Transferrin*/metabolism ; Glucose Transporter Type 1*/Glucose Transporter Type 1*/Glucose Transporter Type 1*/metabolism

  • Source: Cells [Cells] 2024 Jul 11; Vol. 13 (14). Date of Electronic Publication: 2024 Jul 11.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101600052 Publication Model: Electronic Cited Medium: Internet ISSN: 2073-4409

Record details

×
  • 1-10 of  106,468 results for ""Valproic Acid""